Hydrochlorothiazide-induced sympathetic hyperactivity in hypertensive patients

Area of Science:

• Pharmacology
• Cardiovascular Physiology
• Nephrology

Background:

• Hydrochlorothiazide (HCTZ) is a diuretic used to treat hypertension.
• Its antihypertensive effect is linked to diuresis and natriuresis.
• Short-term HCTZ treatment can alter cardiovascular hemodynamics and sympathetic activity.

Purpose of the Study:

• To investigate the effects of short-term and long-term hydrochlorothiazide treatment on cardiac output, peripheral resistance, and plasma norepinephrine levels.
• To elucidate the mechanisms underlying the antihypertensive action of HCTZ.
• To provide a rationale for combination therapy in hypertension.

Main Methods:

• The study involved measuring cardiac output, peripheral resistance, and plasma norepinephrine (NE) levels in subjects undergoing hydrochlorothiazide treatment.
• Hemodynamic parameters and NE levels were assessed after both short-term and longer-term treatment durations.
• Statistical analysis was used to compare changes in these parameters.

Main Results:

• Short-term HCTZ treatment led to decreased cardiac output and increased peripheral resistance, accompanied by elevated plasma NE levels.
• Longer-term HCTZ treatment resulted in a return of cardiac output to normal levels and a decline in peripheral resistance.
• Despite the reduction in peripheral resistance, plasma NE levels remained elevated, indicating that the decrease in resistance was not due to reduced sympathetic activity.

Conclusions:

• The antihypertensive effect of hydrochlorothiazide involves complex cardiovascular and neuroadrenergic adaptations.
• Elevated plasma norepinephrine levels persist even after peripheral resistance reduction with long-term HCTZ use.
• These findings support the combined use of diuretics and drugs that reduce noradrenergic activity for effective hypertension management.